Acadia Pharmaceuticals
August 19, 2026 |
Driven by urgency and the reality that too many patients have few or no treatment options, we are committed to advancing where others hesitate. Inspired by the patients and families who count on us, Acadians across North America, Europe, and beyond dedicate their work to advancing therapies in underserved neurological disorders and rare diseases. Their collective expertise drives innovations that bring meaningful moments and brighter futures to patients and loved ones around the world.